Orgenesis Inc. (ORGS)

Orgenesis Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-45.66	-55.36	-14.89	-18.05	-1.11	24.12
Depreciation & Amortization	1.36	1.56	1.98	1.86	1.44	3.81
Share-Based Compensation	0.62	0.46	0.98	1.75	19.9	5.7
Other Operating Activities	31.64	38.5	-13	-12.42	-98.27	-46.85
Operating Cash Flow	-12.04	-14.84	-24.92	-26.87	-78.05	-13.22
Capital Expenditures	-1.02	-2.1	-12.17	-7.87	-1.52	-12.05
Acquisitions	-1.44	-1.58	-2.73	-3.67	107.11	-1.5
Change in Investments	-0.01	-0.03	0.77	-0.85	0.02	-0.23
Investing Cash Flow	-2.47	-3.71	-14.13	-12.38	105.61	-13.78
Share Issuance / Repurchase	4.36	5.28	2.18	0.91	8.49	0
Debt Issued / Paid	1.22	3.34	16.8	-1.02	-2.61	10.9
Other Financing Activities	5.75	5	20.59	-	-	13.2
Financing Cash Flow	11.32	13.62	39.58	-0.11	5.88	24.1
Exchange Rate Effect	0.02	0.04	-0.13	-0.24	0.08	-0.06
Net Cash Flow	-3.18	-4.93	0.52	-39.36	33.45	-2.9
Free Cash Flow	-13.05	-16.93	-37.09	-34.73	-79.56	-25.27
Free Cash Flow Margin	-2467.49%	-3194.91%	-102.97%	-97.83%	-1039.78%	-648.11%
Free Cash Flow Per Share	-0.39	-0.58	-1.48	-1.43	-3.73	-1.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).